Mc Ilrath & Eck, LLC Becton Dickinson & CO Transaction History

Mc Ilrath & Eck, LLC

$648 Million
Q2 2025

A detailed history of Mc Ilrath & Eck, LLC transactions in Becton Dickinson & CO stock. As of the latest transaction made, Mc Ilrath & Eck, LLC holds 142 shares of BDX stock, worth $27,684. This represents 0.0% of its overall portfolio holdings.

Number of Shares

142

Previous 142 -0.0%

Holding current value

$27,684

Previous $32,000 25.0%

% of portfolio

0.0%

Previous 0.01%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 07, 2023	SELL	$238.39 - $265.32 $1,907 - $2,122	-8 Reduced 5.33%	142 $37,000
Q1 2023 May 08, 2023	BUY	$229.71 - $259.35 $1,837 - $2,074	8 Added 5.63%	150 $37,000
Q1 2022 May 11, 2022	BUY	$243.64 - $270.48 $10,720 - $11,901	44 Added 44.9%	142 $38,000
Q4 2021 Feb 08, 2022	BUY	$230.08 - $250.94 $4,601 - $5,018	20 Added 25.64%	98 $25,000
Q3 2020 Nov 13, 2020	BUY	$215.77 - $276.76 $215 - $276	1 Added 1.3%	78 $18,000
Q2 2020 Aug 04, 2020	SELL	$219.9 - $263.41 $3,518 - $4,214	-16 Reduced 17.2%	77 $18,000
Q1 2020 May 14, 2020	BUY	$195.69 - $279.01 $3,131 - $4,464	16 Added 20.78%	93 $21,000
Q1 2019 May 07, 2019	SELL	$206.05 - $248.17 $5,357 - $6,452	-26 Reduced 25.24%	77 $19,000
Q4 2018 May 07, 2019	SELL	$204.73 - $257.93 $2,661 - $3,353	-13 Reduced 11.21%	103 $23,000
Q2 2018 Aug 07, 2018	BUY	$208.1 - $233.85 $5,410 - $6,080	26 Added 28.89%	116 $28,000
Q1 2018 May 22, 2018	SELL	$205.46 - $240.27 $5,341 - $6,247	-26 Reduced 22.41%	90 $20,000
Q4 2017 Mar 19, 2018	BUY	$189.0 - $222.64 $21,924 - $25,826	116	116 $25,000

Others Institutions Holding BDX

# of Institutions

1,732

Shares Held

259M

Call Options Held

1.89M

Put Options Held

714K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $55.6B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mc Ilrath & Eck, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mc Ilrath & Eck, LLC with notifications on news.

Account